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Pathogenic microbial ancient DNA - a problem or an opportunity? 
The recent review on ancient DNA in this journal by Willerslev and Cooper (2005) is timely. It 
follows more than a decade of intensive research in this area, and others have also seen the need 
to review progress and reflect on the future (Pääbo et al. 2004; Cipollaro et al. 2005; Nicholls 
2005). Since the first papers in this field, the majority of studies have dealt with population 
genetics, diet, domestication, and evolution of mammals and birds. The study of ancient 
microbial DNA developed shortly after, and has led, for example, to studies of bacteria in amber 
(Bada et al. 1999; Greenblatt et al. 2004) and microbes retrieved from the depths of the 
permafrost (Christner et al. 2003). 
  A distinctive branch of ancient DNA research is the study of pathogenic microbial DNA 
within the bodies of infected host species, primarily humans. There is increasing interest in this 
field, but in order to critically assess this body of research, readers should be aware of the 
differences caused by the characteristics of the microbial pathogens, and their distribution within 
the host. 
Microorganisms differ in the susceptibility of their DNA to the initial decay processes 
and the physico-chemical changes over time. Mycobacteria, including the causative agents of 
tuberculosis and leprosy, have resistant hydrophobic cell walls that have been shown to 
physically persist for at least 250 years (Donoghue et al.2004). In addition, they are members of 
a family with DNA rich in guanine and  cytosine which confers greater stability (Pääbo et 
al.2004). Therefore, it is not surprising that M. tuberculosis and M. leprae are the subjects of the 
majority of ancient microbial pathogen papers (Donoghue et al.2004; Drancourt & Raoult 2005). 
In contrast, Treponema pallidum, the causative agent of syphilis, is an exquisitely environmentally sensitive spirochaete, and its DNA very labile. Gram-negative bacteria are a 
little more robust and the DNA may persist in especially protected sites such as dental pulp. 
  Pathogenic microorganisms and their DNA will always be a minor component within a 
host, so it is necessary to know the sites where the particular pathogen will be localised. Initially, 
attention was directed to bony lesions in suspected tuberculosis cases, yet even in the pre-
antibiotic era these were rare, occurring in only 3-6% of cases.  The majority of patients died 
from disseminated disease before lesions had time to form. Lack of understanding this point led 
to classical palaeopathologists querying reports that M.tuberculosis DNA could be detected in 
bones without lesions (reviewed by Donoghue et al.2004; Zink et al. 2005). We have detected 
M.tuberculosis DNA in over 50% of ribs from an 18th century Hungarian population yet <5% 
showed any pathological changes (updated data from Fletcher et al. 2003a). Here, the visceral 
surface closest to the lung was examined, not the inner tissue, and usually the upper ribs where a 
primary focus of infection is most likely.  
  Other diseases are highly localised. M. leprae DNA is primarily found in the cavum 
nasale and maxilla; diarrhoeal diseases are restricted to the intestinal tract, although they may 
spread to the liver, e.g. Schistosoma mansoni (Rutherford 1999). In meningitis, pathogens are 
restricted to the CSF and meninges, so only vertebrae and skull samples may be positive. 
Septicaemic diseases, such as bubonic plague and disseminated tuberculosis, will result in 
pathogen DNA being distributed around the body via the blood. In these cases bone marrow and 
dental pulp should be examined (Wiechmann & Grupe 2004; Drancourt & Raoult 2005). These 
sites should also be examined in suspected cases of blood-borne parasites, for example, of 
malaria (Sallares & Gomzi 2001).  
Syphilis was an early focus of interest because of the clear palaeopathological markers of 
the disease. However, this is a disease where knowledge of its natural history is crucial. Although there is a septicaemic stage of the disease with high numbers of organisms, this is 
rarely the cause of death. It is tertiary syphilis that kills, yet any medical textbook will point out 
that the characteristic lesions of tertiary syphilis contain few, if any spirochaetes. This, together 
with the fragility of the pathogen, explains the negative findings (Bouwman & Brown 2005). 
Examination of human tissues for microbial pathogens requires modification of 
procedures used for extraction of host DNA. Pathogenic species are not normally present in 
healthy individuals, and several, such as Mycobacterium  tuberculosis and  Mycobacterium 
leprae have no known environmental reservoir. Therefore, their detection indicates infection and 
the site may demonstrate whether this was localized or disseminated. Hemi-nested and nested 
PCR are commonly used, due to the initial low number of target molecules. More rigorous DNA 
extraction procedures may be necessary for microbes with persistent cell walls. Contamination 
from investigators is less of a problem, compared with the need to exclude modern human DNA 
from ancient DNA studies. Even so, strict precautions against cross-contamination are taken and 
it is common practice for independent verification to be carried out, often in more than one other 
laboratory (Spigelman et al. 2002; Fletcher et al 2003a,b; Donoghue et al 2005). The use of 
species-specific loci for PCR is widespread, and for those used in clinical diagnostic 
microbiology, there are extensive data on their stability and specificity. This has led to the 
possibility of molecular epidemiological studies (see Donoghue et al. 2004, Drancourt & Raoult 
2005) that throw light on the evolution and spread of microbial pathogens in the past. 
In conclusion, rather than ancient microbial DNA being a problem (Willerslev & Cooper 
2005), we agree with Pääbo et al. (2004) that this field, in particular that of pathogenic microbial 
ancient DNA, is potentially very exciting, and is already reaping results. 
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